NASDAQ:SIBN SI-BONE (SIBN) Stock Price, News & Analysis $15.15 -0.68 (-4.30%) (As of 09/6/2024 ET) Add Compare Share Share Today's Range$14.93▼$16.2150-Day Range$12.90▼$17.1152-Week Range$11.76▼$23.25Volume225,038 shsAverage Volume267,426 shsMarket Capitalization$631.60 millionP/E RatioN/ADividend YieldN/APrice Target$23.00 Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends Get SI-BONE alerts: Email Address SI-BONE MarketRank™ Stock AnalysisAnalyst RatingBuy3.00 Rating ScoreUpside/Downside51.8% Upside$23.00 Price TargetShort InterestHealthy3.74% of Shares Sold ShortDividend StrengthN/ASustainability-1.44Upright™ Environmental ScoreNews Sentiment1.13Based on 5 Articles This WeekInsider TradingSelling Shares$352,179 Sold Last QuarterProj. Earnings GrowthGrowingFrom ($0.89) to ($0.74) Per ShareSee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.4.29 out of 5 starsMedical Sector121st out of 909 stocksSurgical & Medical Instruments Industry17th out of 97 stocks 3.5 Analyst's Opinion Consensus RatingSI-BONE has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 6 buy ratings, no hold ratings, and no sell ratings.Amount of Analyst CoverageSI-BONE has only been the subject of 3 research reports in the past 90 days.Read more about SI-BONE's stock forecast and price target. Previous Next 4.0 Short Interest Percentage of Shares Shorted3.74% of the outstanding shares of SI-BONE have been sold short.Short Interest Ratio / Days to CoverSI-BONE has a short interest ratio ("days to cover") of 4.4.Change versus previous monthShort interest in SI-BONE has recently decreased by 7.69%, indicating that investor sentiment is improving significantly. Previous Next 0.0 Dividend Strength Dividend YieldSI-BONE does not currently pay a dividend.Dividend GrowthSI-BONE does not have a long track record of dividend growth. Previous Next 3.3 Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreSI-BONE has received a 34.81% net impact score from Upright. The largest positive contribution comes from its "Physical diseases" impact, which is false driven by its "Cervical implants" product. See details.Environmental SustainabilityThe Environmental Impact score for SI-BONE is -1.44. Previous Next 2.8 News and Social Media Coverage News SentimentSI-BONE has a news sentiment score of 1.13. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.54 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 5 news articles for SI-BONE this week, compared to 2 articles on an average week.Search InterestOnly 3 people have searched for SIBN on MarketBeat in the last 30 days. This is a decrease of 0% compared to the previous 30 days. Previous Next 2.5 Company Ownership Insider Buying vs. Insider SellingIn the past three months, SI-BONE insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $352,179.00 in company stock.Percentage Held by InsidersOnly 5.40% of the stock of SI-BONE is held by insiders.Percentage Held by Institutions98.11% of the stock of SI-BONE is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about SI-BONE's insider trading history. Previous Next 0.6 Earnings and Valuation Earnings GrowthEarnings for SI-BONE are expected to grow in the coming year, from ($0.89) to ($0.74) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of SI-BONE is -13.90, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of SI-BONE is -13.90, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioSI-BONE has a P/B Ratio of 3.84. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.Read more about SI-BONE's valuation and earnings. Previous Next See Top Rated MarketRank™ Stocks Here Ad Paradigm PressMan who Predicted Trump 2016 Win: “Prepare for Election Meltdown”Former advisor to the CIA, the Pentagon and the White House Jim Rickards went on multiple TV news programs… A predicted Trump would win. You won’t believe what he’s predicting now.Click here to see it because it’s a SHOCKER… About SI-BONE Stock (NASDAQ:SIBN)SI-BONE, Inc., a medical device company, that operate to solve musculoskeletal disorders of the sacropelvic anatomy in the United States and internationally. It offers proprietary minimally invasive surgical implant system to address sacroiliac joint dysfunction and fusion, adult deformity and degeneration, and pelvic trauma; and implantable bone products. The company also provides iFuse-3D, a titanium implant that combines the triangular cross-section of the iFuse implant with the proprietary 3D-printed porous surface and fenestrated design; iFuse-TORQ, a set of 3D-printed threaded implants designed to treat pelvic trauma; and iFuse Bedrock Granite implant provides sacroiliac fusion and sacropelvic fixation as a foundational element for segmental spinal fusion. It markets its products primarily with a direct sales force, as well as through agents and resellers. SI-BONE, Inc. was incorporated in 2008 and is headquartered in Santa Clara, California.Read More SIBN Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart SIBN Stock News HeadlinesSeptember 5 at 7:27 AM | insidertrades.comSI-BONE, Inc. (NASDAQ:SIBN) CFO Sells $23,118.90 in StockAugust 21, 2024 | insidertrades.comInsider Selling: SI-BONE, Inc. (NASDAQ:SIBN) Director Sells 1,580 Shares of StockSeptember 8, 2024 | Paradigm Press (Ad) Fmr CIA Advisor reveals PEACEMAKER superweaponKamala cannot get the “codes” to this superweapon. In Trump’s hands, it will restore America’s global dominance. It could also help Americans struggling under Bidenomics by potentially sending 5 military stocks SOARING. Historically, similar stocks have shot up 16,270% in just 18 months.August 21, 2024 | insidertrades.comSI-BONE, Inc. (NASDAQ:SIBN) Insider Anthony J. Recupero Sells 2,087 SharesSeptember 7 at 12:19 AM | markets.businessinsider.comBuy Rating Justified: SI-Bone’s Growth Potential and Market Expansion OpportunitiesAugust 30, 2024 | ca.finance.yahoo.comSIBN Sep 2024 17.500 callAugust 29, 2024 | ca.finance.yahoo.comSIBN Sep 2024 20.000 callAugust 22, 2024 | globenewswire.comSI-BONE To Present at Morgan Stanley 22nd Annual Global Healthcare Conference on September 4, 2024September 8, 2024 | Paradigm Press (Ad) Fmr CIA Advisor reveals PEACEMAKER superweaponKamala cannot get the “codes” to this superweapon. In Trump’s hands, it will restore America’s global dominance. It could also help Americans struggling under Bidenomics by potentially sending 5 military stocks SOARING. Historically, similar stocks have shot up 16,270% in just 18 months.August 20, 2024 | globenewswire.comSI-BONE, Inc. Receives 510(k) Clearance and FDA Breakthrough Device Designation for Pelvic Fracture Fixation SystemAugust 7, 2024 | markets.businessinsider.comBuy Rating Maintained for SI-Bone Amid Strong Q2 Performance and Promising Growth OutlookAugust 6, 2024 | markets.businessinsider.comBuy Rating Affirmed: SI-Bone’s Financial Success and Growth Trajectory Outshine Market ExpectationsAugust 6, 2024 | seekingalpha.comSI-BONE, Inc. (SIBN) Q2 2024 Earnings Call TranscriptAugust 6, 2024 | msn.comThese Analysts Cut Their Forecasts On SI-BONE Following Q2 ResultsAugust 6, 2024 | insidermonkey.comSI-BONE, Inc. (NASDAQ:SIBN) Q2 2024 Earnings Call TranscriptAugust 6, 2024 | globenewswire.comSI-BONE To Present at Canaccord Genuity 44th Annual Growth Conference on August 14, 2024August 5, 2024 | globenewswire.comSI-BONE, Inc. Reports Financial Results for the Second Quarter 2024July 31, 2024 | investorplace.com7 Leading MedTech Stocks for Next-Gen Health SolutionsSee More Headlines Receive SIBN Stock News and Ratings via Email Sign-up to receive the latest news and ratings for SI-BONE and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings8/05/2024Today9/08/2024Next Earnings (Estimated)11/04/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Surgical & medical instruments Sub-IndustryMedical Equipment Current SymbolNASDAQ:SIBN CUSIPN/A CIK1459839 Webwww.si-bone.com Phone(408) 207-0700FaxN/AEmployees350Year Founded2008Price Target and Rating Average Stock Price Target$23.00 High Stock Price Target$32.00 Low Stock Price Target$18.00 Potential Upside/Downside+51.8%Consensus RatingBuy Rating Score (0-4)3.00 Research Coverage6 Analysts Profitability EPS (Most Recent Fiscal Year)($1.09) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-43,340,000.00 Net Margins-27.10% Pretax Margin-27.10% Return on Equity-24.27% Return on Assets-17.98% Debt Debt-to-Equity Ratio0.22 Current Ratio9.17 Quick Ratio8.12 Sales & Book Value Annual Sales$138.89 million Price / Sales4.55 Cash FlowN/A Price / Cash FlowN/A Book Value$3.95 per share Price / Book3.84Miscellaneous Outstanding Shares41,690,000Free Float38,980,000Market Cap$631.60 million OptionableOptionable Beta1.22 Social Links (Almost) Everything You Need To Know About The EV MarketClick the link below and we'll send you MarketBeat's guide to investing in electric vehicle technologies (EV) and which EV stocks show the most promise. Get This Free Report Key ExecutivesMs. Laura A. Francis MBA (Age 57)CEO & Director Comp: $1.26MMr. Anshul Maheshwari (Age 44)Chief Financial Officer Comp: $705.69kMr. Anthony J. Recupero (Age 65)President of Commercial Operations Comp: $902.11kMr. Jeff BertoliniSenior Vice President of Operations & Information TechnologyDr. Scott A. Yerby (Age 56)Senior VP of Engineering & CTO Saqib IqbalDirector of FP&A and Investor RelationsMr. Michael A. Pisetsky (Age 46)Chief Business & Legal Affairs Officer, Secretary and General Counsel Ms. Aimee EinsteinVice President of People & CultureDr. Daniel Joseph Cher (Age 59)Senior Vice President of Clinical & Regulatory Affairs Dr. W. Carlton Reckling (Age 62)Chief Medical Officer & VP of Medical Affairs More ExecutivesKey CompetitorsOrthofix MedicalNASDAQ:OFIXCryoLifeNYSE:CRYSurmodicsNASDAQ:SRDXIntersect ENTNASDAQ:XENTAntares PharmaNASDAQ:ATRSView All CompetitorsInsiders & InstitutionsAnshul MaheshwariSold 1,414 sharesTotal: $23,118.90 ($16.35/share)Anthony J RecuperoSold 2,087 sharesTotal: $29,572.79 ($14.17/share)Laura FrancisSold 9,967 sharesTotal: $137,943.28 ($13.84/share)Anthony J RecuperoSold 3,905 sharesTotal: $54,045.20 ($13.84/share)Anshul MaheshwariSold 2,418 sharesTotal: $33,537.66 ($13.87/share)View All Insider TransactionsView All Institutional Transactions SIBN Stock Analysis - Frequently Asked Questions How have SIBN shares performed this year? SI-BONE's stock was trading at $20.99 at the beginning of the year. Since then, SIBN shares have decreased by 27.8% and is now trading at $15.15. View the best growth stocks for 2024 here. How were SI-BONE's earnings last quarter? SI-BONE, Inc. (NASDAQ:SIBN) released its earnings results on Monday, August, 5th. The company reported ($0.22) EPS for the quarter, topping the consensus estimate of ($0.26) by $0.04. The company had revenue of $39.97 million for the quarter, compared to analyst estimates of $38.95 million. SI-BONE had a negative trailing twelve-month return on equity of 24.27% and a negative net margin of 27.10%. What is Jeffrey Dunn's approval rating as SI-BONE's CEO? 10 employees have rated SI-BONE Chief Executive Officer Jeffrey Dunn on Glassdoor.com. Jeffrey Dunn has an approval rating of 41% among the company's employees. This puts Jeffrey Dunn in the bottom 10% of approval ratings compared to other CEOs of publicly-traded companies. Does SI-BONE have any subsidiaries? SI-BONE subsidiaries include these companies: SI-BONE Deutschland GmbH, SI-BONE S.R.L., and SI-BONE UK LTD. When did SI-BONE IPO? SI-BONE (SIBN) raised $84 million in an IPO on Wednesday, October 17th 2018. The company issued 6,000,000 shares at $13.00-$15.00 per share. Morgan Stanley and BofA Merrill Lynch served as the underwriters for the IPO and Canaccord Genuity and JMP Securities were co-managers. Who are SI-BONE's major shareholders? SI-BONE's top institutional investors include American Century Companies Inc. (4.82%), Paradigm Capital Management Inc. NY (3.24%), Victory Capital Management Inc. (1.12%) and Dimensional Fund Advisors LP (1.10%). Insiders that own company stock include Laura Francis, Anthony J Recupero, Anshul Maheshwari, Michael A Pisetsky, John Gordon Freund, Timothy E Davis Jr and Mika Nishimura. View institutional ownership trends. How do I buy shares of SI-BONE? Shares of SIBN stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. What other stocks do shareholders of SI-BONE own? Based on aggregate information from My MarketBeat watchlists, some other companies that SI-BONE investors own include CVS Health (CVS), Home Depot (HD), Procter & Gamble (PG), RTX (RTX), Thermo Fisher Scientific (TMO) and Verizon Communications (VZ). This page (NASDAQ:SIBN) was last updated on 9/8/2024 by MarketBeat.com Staff From Our PartnersThe solution to fast food’s wage hike crisisShake Shack will be closing six California locations in response to the recent $20/hour minimum wage increase,...Deal Maker | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | Sponsored44-year Wall Street Vet: “Permanent devastation is coming to America”After 44 years on Wall Street, I've seen it all... Black Monday, the Great Recession, the Covid crash. B...InvestorPlace | SponsoredSay Goodbye to the US DollarThe warning signs are everywhere… According to experts, the United States Dollar is "as good as doomed." ...Sasco Gold LLC | SponsoredMan who Predicted Trump 2016 Win: “Prepare for Election Meltdown”Former advisor to the CIA, the Pentagon and the White House Jim Rickards went on multiple TV news programs… ...Paradigm Press | Sponsored625,000% GainThe recent pullback in the crypto markets has left many investors in full-on panic mode, convinced the bull ru...Crypto Swap Profits | SponsoredLast Call for Crypto Summit (RSVP FREE)The Dow recently shed nearly 1,000 points in a single day… Big tech stocks are getting slaughtered… And ...Crypto 101 Media | SponsoredExposed: 3 CENT Crypto to Explode September 23rd?Chris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding SI-BONE, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share SI-BONE With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
